EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N-terminal half of MED14 is critical for Mediator-RNA polymerase II interaction and the resulting transcription

Yasemin Baris, Javaid Jabbar, Yasemin Yozgat, Melike Dinccelik-Aslan, Ege Cigirgan, Merve Erden, Sadik Bay, Volkan Aslan, Murat Alper Cevher

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Yasemin Baris und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey; Department of Physics and Kavli Institute of Nanoscience Discovery,…. Hauptthemen laut MEDLINE: RNA Polymerase II, Mediator Complex, Transcription, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NCI NIH HHS, European Molecular Biology Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mediator is a large and evolutionarily conserved coactivator complex essential for RNA polymerase II (Pol II)-mediated gene regulation at multiple steps of the transcription process, including preinitiation complex assembly and function. Here, we used the MultiBac baculovirus expression system to generate recombinant human core Mediator subcomplexes and subsequent biochemical approaches to dissect the mechanism by which Mediator facilitates recruitment of Pol II to core promoters. Our results highlight a pivotal role in this process for the N-terminal half of the MED14 (MED14-NTD) subunit. We show that a reconstituted 15-subunit human core Mediator complex that contains only the MED14- NTD is fully functional in facilitating both basal and activated (p53) transcription. This complex directly interacts with the RPB1 subunit of Pol II and is required for recruiting Pol II to core promoters. LC-MS/MS analysis of Mediator-bound RPB1 indicates that the CTD is predominantly hypophosphorylated (≤1% detectable Ser5-P), consistent with recruitment-stage engagement. Moreover, recombinant RPB1 can completely reverse the human core Mediator-Pol II interaction. Notably, the human MED14-NTD region has secondary structure conservation with Schizosaccharomyces pombe. In addition, reanalysis of published cryo-EM structures of yeast Mediator-Pol II complexes strongly supports our conclusion. Thus, our analyses provide critical new insights into how Mediator binds to Pol II and recruits it to the promoters to facilitate transcription.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Polymerase IIMediator ComplexTranscription, GeneticHumansPromoter Regions, GeneticTumor Suppressor Protein p53Protein BindingProtein Domains

Stichwörter der Autor:innen

Mediator complexco-activatorgene regulationin vitro transcriptiontranscription

Substanzen

RNA Polymerase IIMediator ComplexTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey; Department of Physics and Kavli Institute of Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.
  • Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Vic…
  • Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey; Department of Medical Biology, International Medical School, Istanbul Medipol University, Istanbul, Turkey.
  • Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
  • Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey; Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany.
  • Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey; UNAM, Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center, Bilkent University, Ankara, Turkey.

Förderung

  • NIDCD NIH HHS
  • NCI NIH HHS
  • European Molecular Biology Organization
  • National Institutes of Health
  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
  • Rockefeller University
  • Leona M. and Harry B. Helmsley Charitable Trust

Zitieren

APA

Baris, Y., Jabbar, J., Yozgat, Y., Dinccelik-Aslan, M., Cigirgan, E., Erden, M., Bay, S., Aslan, V., & Cevher, M. A. (2025). N-terminal half of MED14 is critical for Mediator-RNA polymerase II interaction and the resulting transcription. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110837

Vancouver

Baris Y, Jabbar J, Yozgat Y, Dinccelik-Aslan M, Cigirgan E, Erden M, et al. N-terminal half of MED14 is critical for Mediator-RNA polymerase II interaction and the resulting transcription. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110837

BibTeX
@article{Baris2025,
  author = {Baris, Yasemin and Jabbar, Javaid and Yozgat, Yasemin and Dinccelik-Aslan, Melike and Cigirgan, Ege and Erden, Merve and Bay, Sadik and Aslan, Volkan and Cevher, Murat Alper},
  title = {N-terminal half of MED14 is critical for Mediator-RNA polymerase II interaction and the resulting transcription},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110837}
}
Kostenlos starten →